| Term 
 
        | what is the functions of folates (5) |  | Definition 
 
        | make purines and primidines growth
 replication
 cell division
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | how do bacteria get folate (3) |  | Definition 
 
        | make it from PABA, pteridine, glutamine |  | 
        |  | 
        
        | Term 
 
        | what are the 6 antifolate drugs |  | Definition 
 
        | sulfonamide/trimethoprim silver sulfadizine
 sulfacetamidine
 pyrimetnamine
 dapsone
 methotraxate
 |  | 
        |  | 
        
        | Term 
 
        | what does pyrimetnamine treat |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what does methotrexate treat (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 3 DNA antibiotics |  | Definition 
 
        | metronidazole daptomycin
 floroquinolones
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 1st gen floroquinolones |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 2st gen floroquinolones (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 3st gen floroquinolones (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 4st gen floroquinolones |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | is sulfonamide bacteriostatic or cidial |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | is metronidazole bacteriostatic or cidial |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | is nitrofurantoin bacteriostatic or cidial |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the MOA of trimethoprim sulfamethoxazole |  | Definition 
 
        | competitive inhibitor for dihydrofolate reductase in conversion of folic acid to nucleotides |  | 
        |  | 
        
        | Term 
 
        | why is TMP/SMX in the combo (2) |  | Definition 
 
        | prevents formation of tetrahydrofolic acid have greater activity together
 |  | 
        |  | 
        
        | Term 
 
        | what can cause resistance to TMP/SMX (2) |  | Definition 
 
        | not common with two drugs over use
 alteration of dihydrofolate reductase
 |  | 
        |  | 
        
        | Term 
 
        | how is TMP/SMX administered (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | where does TMP/SMX distribute to |  | Definition 
 
        | trimethloprim part concentrates in prostatic and vaginal fluid |  | 
        |  | 
        
        | Term 
 
        | what are 4 adverse effects of TMP/SMX |  | Definition 
 
        | all the sulfonamide side effects 
 in G6PDH deficiency it causes anemia
 
 rash: commonly in elderly and HIV
 
 marrow supression
 |  | 
        |  | 
        
        | Term 
 
        | what types of marrow suppression occur with TMP/SMX (3), how can you fix it |  | Definition 
 
        | megaloblastic aemia leukopenia
 thrombocytopenia
 
 give folic A
 |  | 
        |  | 
        
        | Term 
 
        | in general what does TMP/SMX work on (5) |  | Definition 
 
        | broad spectrum - but lots resistant gram positive, negative, rod, cocci
 |  | 
        |  | 
        
        | Term 
 
        | what is TMP/SMX the drug of choice for |  | Definition 
 
        | prevention and tx of PJ pneumonia |  | 
        |  | 
        
        | Term 
 
        | what is TMP/SMX the second in line for drug of choice for |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what specific microbes does TMP/SMX treat (5) |  | Definition 
 
        | listeria CA-MRSA
 moraxella
 E. coli (UTI)
 PJ pneumonia
 |  | 
        |  | 
        
        | Term 
 
        | what is the MOA of sulfonamides |  | Definition 
 
        | compete with PABA for dihydroperoate synthase stop folic A synthesis
 |  | 
        |  | 
        
        | Term 
 
        | how do you get resistance to sulfonamides (3) |  | Definition 
 
        | altered dihydroperoate synthesis via mutation or plasmid transfer 
 decreased sulfonamide uptake
 
 increased PABA
 |  | 
        |  | 
        
        | Term 
 
        | what are the type types of sulfonamides, how are they administered |  | Definition 
 
        | sulfacetamide: ointment, drops silver sulfadiazine: cream
 |  | 
        |  | 
        
        | Term 
 
        | what are the side effects of sulfonamides (6) |  | Definition 
 
        | burning brown gray discoloration blurred vision
 hypersensitivity - oral rash, angioedema, steven johnson syndrome
 |  | 
        |  | 
        
        | Term 
 
        | what are three symptoms of steven johnson syndrome |  | Definition 
 
        | erythema, hemorrhages, crust on lips |  | 
        |  | 
        
        | Term 
 
        | what has cross allergenicity with sulfonamides (4) |  | Definition 
 
        | carbonic anhydase inhibitors thiazide diruetics
 loop duiruetics
 sulfonyl urea hypoglycemia drugs
 |  | 
        |  | 
        
        | Term 
 
        | what in general are sulfanomides used for (5 conditions, 3 organisms) |  | Definition 
 
        | gram negative and positive yeast
 sepsis prevention in burns
 conjunctivitis
 corneal infection
 UTI
 |  | 
        |  | 
        
        | Term 
 
        | what is the MOA of maternidazole (2) |  | Definition 
 
        | activated by ferrdoxin in anaerobes via reduction 
 messes with DNA
 |  | 
        |  | 
        
        | Term 
 
        | how is metronidazole administered |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how is metronidazole metabolized |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the adverse effects of metronidazole (4) |  | Definition 
 
        | gi upset metalic taste
 red brown urine
 disulfrum reaction
 |  | 
        |  | 
        
        | Term 
 
        | what causes resistance to metronidazole/what is it not good against (3) |  | Definition 
 
        | oxygen inhibits no aerobic activity
 no pesudomonas
 |  | 
        |  | 
        
        | Term 
 
        | explain the disulfrim reaction |  | Definition 
 
        | blocks acetylaldehyde DH and acid aldehyde builds up |  | 
        |  | 
        
        | Term 
 
        | what in general does metronidazole kill (5) |  | Definition 
 
        | anaerobes, parasites, protozoa, empiric for anaerobic and mixed infections |  | 
        |  | 
        
        | Term 
 
        | what are specific organisms matronidazole kills (6) |  | Definition 
 
        | giardia etenobea
 trichomonas
 bacteroides
 anaerobes
 clostridium
 
 on the
 
 metronidazole
 
 gardenela (bacterial vaginosis)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds bacterial cell membrane and depolarizes it causing loss of potential and inhibiting DnA/RNA synthesis |  | 
        |  | 
        
        | Term 
 
        | how is daptomycin administered, how long |  | Definition 
 
        | IV over 30 minutes once a day for 1-2 weeks |  | 
        |  | 
        
        | Term 
 
        | what are the 5 adverse effects of daptomycin |  | Definition 
 
        | constipation nausea
 abnormal LFT
 muscle pain
 weakness
 |  | 
        |  | 
        
        | Term 
 
        | what is daptomycin used for (5) |  | Definition 
 
        | complicated skin and skin structure infections staph
 MRSA
 gram positive cocci
 |  | 
        |  | 
        
        | Term 
 
        | what is the MOA of flouroquinolones |  | Definition 
 
        | inhibit DNA gyrase (topoisomerase II) preventing relaxation of supercoils stipping transcription prevents joining of gyrase
 |  | 
        |  | 
        
        | Term 
 
        | what does DNA gyrase normally do |  | Definition 
 
        | changes DNA configuration by nicking, pass through, and resealing |  | 
        |  | 
        
        | Term 
 
        | what can cause resistance to flouroquinolones (3) |  | Definition 
 
        | mutation of DNA gyrase eflux of the drug
 prevention of drug penetration
 |  | 
        |  | 
        
        | Term 
 
        | how are flouroquinolones administered |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | where do flouroquinolones distribute to (6) |  | Definition 
 
        | tissue, bone, urine, kidney, prostate, lung |  | 
        |  | 
        
        | Term 
 
        | where are foluroquinolones excreted |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the adverse effects of foluroquinolones (6) |  | Definition 
 
        | generally well tolerated gi upset
 phototoxicity
 tendinitis
 rupture
 affects collagen metabolism
 affects cartiladge development
 |  | 
        |  | 
        
        | Term 
 
        | what interacts with foluroquinolones |  | Definition 
 
        | avoid antacidsL Mg, Al, Zn, Fe 
 cipro inhibits P450 and interferes with theophylline metabolism
 |  | 
        |  | 
        
        | Term 
 
        | what can foluroquinolone generations 1 and 2 kill that the others cant (2) |  | Definition 
 
        | cipro can kill bacillus anthracis, pseudomonas |  | 
        |  | 
        
        | Term 
 
        | what can gen 3 and 4 fouroquinolones kill that the others cant(5) |  | Definition 
 
        | strep, enterococcus, fecalis anaerobes: c not diff, bacteroides
 |  | 
        |  | 
        
        | Term 
 
        | what general categories can foluroquinolones kill |  | Definition 
 
        | gram negative first choice except pseudomonas atypicals
 newer drugs gram positives
 |  | 
        |  | 
        
        | Term 
 
        | what are flouroquinolones first choice for |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what atypicals can fouroquinolones kill (3) |  | Definition 
 
        | candidia, mycoplasma, legionalla |  | 
        |  | 
        
        | Term 
 
        | what do you use when a pneumonia is resistant to macrolides and penicillins |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what random microbes can all foluroquinolones kill that are not atypical (6) |  | Definition 
 
        | listeria strep pneumonia
 neisseria
 moraxella
 chylamydia
 MSSA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | boys <6yo without circumcision girls 1-5yo, teens, puberty, and sexually active women
 eldery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | e. coli, staph saphrophiticus, klevsiella, proteus, pseudomonas aeruginosa |  | 
        |  | 
        
        | Term 
 
        | what are the symptoms of UTI (5) |  | Definition 
 
        | asymptomatic, urgency, frequency, nocturia, suprapubic heaviness |  | 
        |  | 
        
        | Term 
 
        | what are the symptoms of UTI in the elderly (2) |  | Definition 
 
        | altered mental status, changes in eating |  | 
        |  | 
        
        | Term 
 
        | what is used to treat a complicated UTI (2) |  | Definition 
 
        | TMP/SMX, foluroquinolones |  | 
        |  | 
        
        | Term 
 
        | what is used to treat a uncomplicated UTI (3) |  | Definition 
 
        | gentamycin, anti-pseudomonal penicillin, nitrofurantoin |  | 
        |  | 
        
        | Term 
 
        | what is the MOA of nitrofurantoin (3) |  | Definition 
 
        | bacteria activate the drug it inhibits enzymes and damaes DNA
 |  | 
        |  | 
        
        | Term 
 
        | how do you get resistance to nitrofurantoin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how is nitrofurantoin administered |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | is nitrofurantoin teratogenic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the adverse effects of nitrofurantoin (4) |  | Definition 
 
        | GI upset- take with food pulmonary: pneumonitis, fibrosis with chronic treatment
 turns urine brown
 |  | 
        |  | 
        
        | Term 
 
        | what does nitrofurantoin kill ((4) |  | Definition 
 
        | e. coli gonorrhea
 MSSA
 strep
 |  | 
        |  | 
        
        | Term 
 
        | what is hte MOA of probencid |  | Definition 
 
        | inhibit tubular reabsorption of uric acid and increase excretion |  | 
        |  | 
        
        | Term 
 
        | what does probencid interact with (4) |  | Definition 
 
        | inhibits secretion of penicillins, cephalosporins, and foluroquinolones 
 increases half life of WA antibiotics
 |  | 
        |  | 
        
        | Term 
 
        | what is the number one and two choice of tx for gonorrhea |  | Definition 
 
        | 1. ceftriaxone 2. flouroquinolone
 |  | 
        |  | 
        
        | Term 
 
        | what is the treatment for syphilos |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the number 1 and 2 treatment for chalmydia trachomatis |  | Definition 
 
        | 1. asithromycin 2. doxycycline
 |  | 
        |  | 
        
        | Term 
 
        | what are the 5 antibiotics that are not excreted renal |  | Definition 
 
        | anti-staph penicillins cephtriaxone
 doxycycline
 macrolides
 clindamycin
 metronidazole
 |  | 
        |  |